Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: Stephen How who wrote (2769)	9/16/1998 5:35:00 PM
From: mesaone	Read Replies (1) \| Respond to of 4634

steve, come on.. no guts, no glory.. i think you should short BTIM now.. but more than 500 shares. I'd like at least another million or so shorted. Your analysis of hextend is about to be proven wrong. I saw the research with my own eyes and Hextend will capture the albumin market You are about to be proven wrong by over 26 non-BTIM scientists and doctors, stephen. I remain very long on this stock, and welcome anyone to do their own DD, check out my web site (for important letters from the FDA to the medical community). Today volume was 245,000 shares.. hmmmm.... something must be up. inch.com